Why are you looking at Hemoglobin Oxygen Therapeutics?
Email me when a Hemoglobin Oxygen Therapeutics recompete window opens.
Capability
Service linesRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Work mix: 100% prime · 0% sub · primary NAICS 541715 / PSC AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Where they win
Sole agencyMostly sole-source · 100%
100% of Hemoglobin Oxygen Therapeutics’s obligations are not openly competed — these contracts typically renew with the incumbent rather than going to recompete.
Agency buyer map
1 buyersRecompete exposure
NoneLargely sole-source — these contracts typically renew with Hemoglobin Oxygen Therapeutics rather than being openly recompeted.
SCOUT does not currently show incumbent recompetes for Hemoglobin Oxygen Therapeutics in the next 24 months.
The rest of this firm’s 24-month recompete book is not on this page yet. Open the live SCOUT company view.
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Hemoglobin Oxygen Therapeutics hold?
Hemoglobin Oxygen Therapeutics (UEI UJAMF5FC81N9) shows $9.6M across 1 award actions in SCOUT’s public USASpending-backed profile, with Department of Defense (DOD) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Hemoglobin Oxygen Therapeutics have?
Hemoglobin Oxygen Therapeutics shows $9.6M across 1 award actions.
Which agencies does Hemoglobin Oxygen Therapeutics work with?
Hemoglobin Oxygen Therapeutics’s firm-wide obligated mix is led by Department of Defense (DOD) (100%).
What is the UEI for Hemoglobin Oxygen Therapeutics?
The Unique Entity ID (UEI) for Hemoglobin Oxygen Therapeutics is UJAMF5FC81N9.
Seen enough? Run one full capture cycle on Hemoglobin Oxygen Therapeutics — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.